HeHealth’s AI app that screened ‘dick pics’ for STIs has shut down

HeHealth’s AI-powered Calmara app claimed, “Our revolutionary AI know-how provides speedy, confidential, and scientifically validated sexual well being screening, supplying you with peace of thoughts earlier than diving into intimate encounters,” however now it’s shut down after an inquiry by the Federal Commerce Fee (FTC).

The app prompted daters to submit dick pics to verify for sexually transmitted infections, promising “clear, science-backed solutions about your companion’s sexual well being standing,” in line with an FTC letter dated July eleventh. The letter lays out a number of the company’s issues with the knowledge HeHealth relied on for its claims, together with one saying that it might detect greater than 10 sexually transmitted infections with as much as 94 p.c accuracy.

The FTC notes that HeHealth paid a number of examine authors, that the principle examine cited by the corporate solely assessed 4 sorts of STIs reasonably than 10, and knowledge used to coach the AI mannequin included photographs from customers who by no means bought a diagnostic check to verify the outcomes.

The HeHealth app, which makes use of the identical AI, marketed itself extra as an preliminary step for people earlier than connecting with a medical supplier.

The corporate agreed to close down each of the apps by July fifteenth, and Calmara’s web site and hyperlinks to the HeHealth app look like offline. The corporate additionally agreed to delete all private info from clients obtained via the apps or cost distributors and request these distributors to delete any knowledge on their clients, the FTC stated.

“The FTC is so dedicated to defending shoppers that it’s even prepared to wade via pages of dick pics to guard Individuals from AI scammers,” a supply acquainted with the matter, granted anonymity as a result of they weren’t approved to touch upon the file in regards to the investigation, instructed The Verge.

The FTC issued a civil investigative demand (just like a subpoena) looking for details about Calmara’s promoting claims and privateness practices and put HeHealth on discover that it’s unlawful to make well being profit claims with out “dependable scientific proof.”

HeHealth didn’t instantly reply to a request for remark from The Verge.

The FTC stated it will not pursue the investigation additional since HeHealth agreed to these phrases and due to “the small variety of Calmara customers and gross sales within the U.S.” However, it warned, “The Fee reserves the proper to take such additional motion as the general public curiosity might require.”